Attenuation of age-related metabolic dysfunction in mice with a targeted disruption of the Cβ subunit of protein kinase A

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 12, 2009, Pages 1221-1231

  Enns, Linda C ^a   Morton, John F ^a   Mangalindan, Ruby Sue ^a   McKnight, G Stanley ^b   Schwartz, Michael W ^b   Kaeberlein, Matt R ^b   Kennedy, Brian K ^a   Rabinovitch, Peter S ^b   Ladiges, Warren C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Department of Pharmacology ^*  (United States)

Author keywords

Aging; Insulin sensitivity; Metabolic syndrome; Obesity resistance; PKA C

Indexed keywords

ANIMALIA; MAMMALIA; MUS; RODENTIA;

CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; PROTEIN KINASE A CALPHA;

AGING; ANIMAL; ARTICLE; BODY COMPOSITION; C57BL MOUSE; CARBOHYDRATE DIET; COMPARATIVE STUDY; DISEASE MODEL; FAT INTAKE; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; INSULIN RESISTANCE; LIPID METABOLISM; LONGEVITY; METABOLIC SYNDROME X; METABOLISM; MOUSE; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; RANDOMIZATION; SIGNAL TRANSDUCTION;

AGING; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; CYCLIC AMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNITS; DIETARY CARBOHYDRATES; DIETARY FATS; DISEASE MODELS, ANIMAL; IMMUNOBLOTTING; INSULIN RESISTANCE; LIPID METABOLISM; LONGEVITY; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; OBESITY; PROBABILITY; RANDOM ALLOCATION; SIGNAL TRANSDUCTION;

EID: 75949106184     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glp133     Document Type: Article

References (60)

1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-193.
2. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD. Regulation of longevity and stress resistance by Sch9 in yeast. Science 2001;292:288-290.
3. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289:2126-2128.
4. Jorgensen P, Rupes I, Sharom JR, Schneper L, Broach JR, Tyers M A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 2004;18: 2491-2505.
5. Martin DE, Soulard A, Hall MN. TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1. Cell. 2004;119:969-979.
6. McKnight GS, Cummings DE, Amieux PS, et al. Cyclic AMP, PKA, and the physiological regulation of adiposity. Recent Prog Hormone Res. 1998;53:139-161.
7. Robinson SW, Dinulescu DM, Cone RD. Genetic models of obesity and energy balance in the mouse. Annu Rev Genet. 2000;34:687-745.
8. McKnight GS. Differential expression of mRNAs for protein kinase inhibitor isoforms in mouse brain. Curr Opin Cell Biol. 1991;3: 213-217.
9. Brandon EP, Idzerda RL, McKnight GS. PKA isoforms, neural pathways, and behaviour: making the connection. Curr Opin Neurobiol 1997;7:397-403.
10. Desseyn JL, Burton KA, McKnight GS. Expression of a nonmyri-stylated variant of the catalytic subunit of protein kinase A during male germ-cell development. Proc Natl Acad Sci USA. 2000;97: 6433-6438.
11. Guthrie CR, Skalhegg BS, McKnight GS. Two novel brain-specifi c splice variants of the murine Cbeta gene of cAMP-dependent protein kinase. J Biol Chem. 1997;272:29560-29565.
12. Howe DG, Wiley JC, McKnight GS. Molecular and behavioural effects of a null mutation in all PKA C b isoforms. Mol Cell Neurosci 2002;20:515-524.
13. Leiter EH, Le PH, Coleman DL. Susceptibility to db gene and strepto-zotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits. Immunogenetics. 1987;26:6-13.
14. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly DP. A gender-related defect in lipid metabolism and glucose homeostastis in peroxisome proliferator-activated receptor a-defi cient mice. J Clin Invest. 1998;102:1083-1091.
15. Hong J, Stubbins RE, Smith RR, Harvey AE, Núñez NP. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nut J. 2009;8:11-15.
16. Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII b subunit of protein kinase A. Nature. 1996;382:622-626.
17. Schreyer SA, Cummings DE, McKnight GS, LeBoeuf RC. Mutation of the RII b subunit of protein kinase A prevents diet-induced insulin resistance and dyslipidemia in mice. Diabetes. 2001;50:2555-2562.
18. Czyzyk TA, Sikorski MA, Yang L, McKnight GS. Disruption of the RII b subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice. Proc Natl Acad Sci USA. 2008;105:276-281.
19. Newhall KJ, Cummings DE, Nolan MA, Mcknight GS. Deletion of the RII b-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-defi cient ob/ob mouse. Mol Endocrinol. 2005;19:982-991.
20. Enns LC, Morton JF, Treuting PR, et al. Disruption of protein kinase A in mice enhances healthy aging. PLoS ONE. 2009;4:e5963.
21. Butera PC, Czaja JA. Intracranial estradiol in ovariectomized guinea pigs: effects on ingestive behaviors and body weight. Brain Res 1984;322:41-48.
22. Dubuc PU. Effects of estrogen on food intake, body weight, and temperature of male and female obese mice. Proc Soc Exp Biol Med 1985;180:468-473.
23. Palmer K, Gray JM. Central vs peripheral effects of estrogen on food intake and lipoprotein lipase activity in ovariectomized rats. Physiol Behav. 1986;37:187-189.
24. Gamm DM, Baude EJ, Uhler MD. The major catalytic subunit iso-forms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo. J Biol Chem. 1996;271:15736-15742.
25. Muzumdar R, Allison DB, Huffman DM, et al. Visceral adipose tissue modulates mammalian longevity. Aging Cell. 2008;7:438-440.
26. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005;183:308-315.
27. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JCN. Sonographic measurements of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes. 2003;27:1267-1273.
28. Liu KH, Chan YL, Chan WB, Chan JCN, Chu CWW. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifi es subjects with increased carotid intima-media thickness. Diabetes Care. 2006;29:379-384.
29. Exton JH. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab Rev. 1987;3:163-183.
30. Pilkis SJ, Claus TH el-Maghrabi MR. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis. Adv Sec Mess Phosphoprot Res. 1988;22:175-191.
31. Herzig S, Long F, Jhala US, et al. CREB regulates hepatic gluconeo-genesis through the coactivator PGC-1. Nature. 2001;413:179-183.
32. Yamashita H, Takenoshita M, Sakurai M, et al. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci USA. 2001;98:9116-9121.
33. Uyeda K, Yamashita H, Kawaguchi T. Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage. Biochem Pharmacol. 2002;63:2075-2080.
34. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K. Defi ciency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA. 2004;101: 7281-7286.
35. Ishii S, Iizuka K, Miller BC, Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA. 2004;101:15597-15602.
36. Dentin R, Benhamed F, Hainault I, et al. Liver-specifi c inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006;55:2159-2170.
37. Hadley AJ, Flack JD, Buckingham JC. Effects of selective phosphodi-esterase inhibitors on the release of ACTH and LH from the rat pituitary gland in vitro. Pharmacol Comm. 1993;3:283-295.
38. Hadley AJ, Kumari M, Cover PO, Osborne J, Flack JD, Buckingham JC. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4-phosphodiesterase (PDE-4) inhibitor denbufylline. Br J Pharmacol. 1996;119:463-470.
39. Lamers WH, Hanson RW, Meisner HM. cAMP stimulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase in rat liver nuclei. Proc Natl Acad Sci USA. 1982;79:5137-5141.
40. Lange AJ, Argaud D, el Maghrabi MR, Pan W, Maitra SR, Pilkis S J Isolation of a cDNA for the catalytic subunit of rat liver glucose-6- phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. Biochem Biophys Res Commun 1994;201:302-309.
41. Schmoll D, Wasner C, Hinds CJ, Allan BB, Walther R, Burchell A. Iden-tifi cation of a cAMP response element within the glucose-6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells. Biochem J. 1999;338:457-463.
42. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-455.
43. Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev. 2002;7:276-291.
44. Koo S-H, Montminy M. Fatty acids and insulin resistance: A perfect storm. Mol Cell. 2006;21:449-450.
45. Al-Majed HT, Jones PM, Persaud SJ, Sugden D, Huang GC, Amiel S Whitehorse BJ. ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans. J Endocrinol 2004;180:155-166.
46. Xu N, Ekstrom U, Nilsson-Ehle P. ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures. J Biol Chem 2001;276:38680-38684.
47. Kenyon C. A conserved regulatory system for aging. Cell 2001;105:165-168.
48. Longo VD, Fabrizio P. Regulation of longevity and stress resistance: a molecular strategy conserved from yeast to humans? Cell Mol Life Sci 2002;59:903-908.
49. Yan L, Vatner DE, O'Connor JP, et al. Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell. 2007;130: 247-258.
50. Fabrizio P, Gattazzo C, Battistella L, Wei M, Cheng C, McGrew K Longo V. Sir2 blocks extreme life-span extension. Cell. 2005;123: 655-667.
51. Kaeberlein M, Kirkland KT, Fields S, Kennedy BK. Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2004;2:E296.
52. Steffen KK, MacKay VL, Kerr EO, et al. Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell 2008;133:292-302.
53. Kaeberlein M, Kennedy BK. Protein translation. Aging Cell. 2007;6: 731-734.
54. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996;273:59-63.
55. Yu BP. Aging and oxidative stress: modulation by dietary restriction. Free Radical Biol Med. 1996;21:651-668.
56. Kuczmarski RJ, Flegal KM, Campbell SM, Johson CL. Increasing prevalence of overweight among U.S. adults. The National Health and Nutrition Examination Surveys, 1960 to 1991 (NHANES III). JAMA 1994;272:238-239.
57. Enzi G, Gasparo M, Binodetti PR, Fiore D, Semisa M, Zurlo F Subcutaneous and visceral fat distribution according to sex, age and overweight, evaluated by computed tomography. Am J Clin Nutr 1986;44:739-746.
58. Fraze E, Chlou M, Chen Y, Reaven GM. Age related changes in postprandial plasma glucose, insulin, and FFA concentrations in non-diabetic individuals. J Am Geriatr Soc. 1987;35:212-218.
59. Calle EE, Thun JM, Petrelli JM, Rodriguez C, Heath JCW. Body-mass index and mortality in a prospective cohort. N Engl J Med 1999;341:1097-1102.
60. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C Prospective study of intentional weight loss and mortality in never-smoking overweight U.S. white women aged 40-64 years. Am J Epidemiol. 1995;141:1128-1141